Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WASP-family verprolin homologous protein 1 (WAVE1), encoded by the WASF1 gene, is a critical scaffolding protein involved in the regulation of the actin cytoskeleton [1][2]. It operates as part of the pentameric WAVE regulatory complex (WRC), which translocates to the plasma membrane upon activation by the small GTPase Rac1 to stimulate the Arp2/3 complex [4]. This activation leads to the formation of branched actin networks, which are essential for the generation of lamellipodia and driving cell motility [4]. In the central nervous system, WAVE1 is highly expressed and plays a vital role in neuronal morphogenesis, including the development of axons and dendritic spines, which are fundamental for synaptic plasticity and cognitive function [1][3]. Pathologically, WAVE1 is frequently upregulated in various malignancies, where it promotes tumor cell invasion and metastasis by enhancing migratory capacity [5]. Furthermore, de novo mutations in WASF1 have been identified as a cause of Sohal-Siddiqui syndrome, a neurodevelopmental disorder characterized by intellectual disability and autistic features [3]. While WAVE1 is a promising therapeutic target for inhibiting cancer metastasis and treating certain neurological conditions, there are currently no FDA-approved drugs that directly target this protein [2][5]. [1] UniProt (Q92558); [2] NCBI Gene (8936); [3] Sohal et al. (2021) PMID: 33536283; [4] Takenawa & Suetsugu (2007) PMID: 17183360; [5] Kurisu & Takenawa (2009) PMID: 19923894.
Acts as a downstream effector of Rac1 within the WAVE regulatory complex (WRC) to activate the Arp2/3 complex, which nucleates branched actin filament assembly at the leading edge of cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WASP-family verprolin homologous protein 1 (WAVE1).